Torin R. Weisbrod

Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid

Catherine Vilchèze, Feng Wang, Masayoshi Arai et al. · Nature Medicine · 2006 · 321 citations

Pulmonary Tuberculosis, Pathogenesis, Tuberculosis Prevention +8

Altered NADH/NAD ⁺ Ratio Mediates Coresistance to Isoniazid and Ethionamide in Mycobacteria

Catherine Vilchèze, Torin R. Weisbrod, Bing Chen et al. · Antimicrobial Agents and Chemotherapy · 2005 · 279 citations · Full text

Intracellular Nadh/nad, Bacteriology, Molecular Biology +17

Inactivation of the <i>inhA</i> -Encoded Fatty Acid Synthase II (FASII) Enoyl-Acyl Carrier Protein Reductase Induces Accumulation of the FASI End Products and Cell Lysis of <i>Mycobacterium smegmatis</i>

Catherine Vilchèze, Héctor R. Morbidoni, Torin R. Weisbrod et al. · Journal of Bacteriology · 2000 · 278 citations

In vivo growth characteristics of leucine and methionine auxotrophic mutants of Mycobacterium bovis BCG generated by transposon mutagenesis

Ruth A. McAdam, Torin R. Weisbrod, Jean Martin et al. · Infection and Immunity · 1995 · 209 citations · Full text

Engineering, Genetics, Bacteriology +18

Efflux pump of the proton antiporter family confers low-level fluoroquinolone resistance in Mycobacterium smegmatis.

Howard Takiff, Mena Cimino, Marco Musso et al. · Proceedings of the National Academy of Sciences · 1996 · 197 citations · Full text

Efflux Pump, Molecular Biology, Antibiotic Resistance +17